U.S. federal trademark · Serial No. 99975230 · Reg. No. 8372911
Pharmaceuticals for the treatment, prevention, mitigation, and management of cancer, genitourinary, oncological, respiratory, gastrointestinal, dermatological, immune system-related, autoimmune, rheumatological, and age-related diseases and disorders; therapeutics, namely, therapeutic agents for the treatment, prevention, mitigation, and management of cancer, genitourinary, oncological, respiratory, gastrointestinal, dermatological, immune system-related, autoimmune, rheumatological, and age-related diseases and disorders; small molecule therapeutics, namely, therapeutic agents for the treatment, prevention, mitigation, or management of cancer, genitourinary, oncological, respiratory, gastrointestinal, dermatological, immune system-related, autoimmune, rheumatological, and age-related diseases and disorders; small molecule pharmaceuticals for the treatment, prevention, mitigation, or management of cancer, genitourinary, oncological, respiratory, gastrointestinal, dermatological, immune system-related, autoimmune, rheumatological, and age-related diseases and disorders
Scientific research, namely, research and analysis services for the design and characterization of chemical therapeutic products; research services in the fields of proteomic analysis; proteomic analysis for scientific and research purposes; medical and scientific research in the field of proteomics; research and development in the field of proteomics; medical research, namely, compiling data for research purposes in the field of proteomics
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.